{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:09:42Z","timestamp":1777856982117,"version":"3.51.4"},"reference-count":39,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2020,1,22]]},"DOI":"10.3233\/jnd-190430","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T12:25:06Z","timestamp":1579868706000},"page":"51-60","source":"Crossref","is-referenced-by-count":2,"title":["Identification and Functional Analysis of RYR1 Variants in a Family with a Suspected Myopathy and Associated Malignant Hyperthermia"],"prefix":"10.1177","volume":"7","author":[{"given":"Anja H.","family":"Schiemann","sequence":"first","affiliation":[{"name":"School of Fundamental Sciences, Massey University, Manawatu, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Roesl","sequence":"additional","affiliation":[{"name":"School of Fundamental Sciences, Massey University, Manawatu, New Zealand"},{"name":"Present address: LifeArc, Nine, Edinburgh BioQuarter, Edinburgh, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Pollock","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Intensive Care, Palmerston North Hospital, Manawatu, New Zealand"},{"name":"Now retired"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Langton","sequence":"additional","affiliation":[{"name":"Wellington Regional Hospital, Wellington, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terasa","family":"Bulger","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Intensive Care, Palmerston North Hospital, Manawatu, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn M.","family":"Stowell","sequence":"additional","affiliation":[{"name":"School of Fundamental Sciences, Massey University, Manawatu, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"1","key":"10.3233\/JND-190430_ref1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/archneur.61.1.27","article-title":"Multiminicore myopathy, central core disease, malignant hyperthermia susceptibility, and RYR1 mutations: one disease with many faces?","volume":"61","author":"Mathews","year":"2004","journal-title":"Arch Neurol"},{"issue":"4","key":"10.3233\/JND-190430_ref2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.nmd.2007.01.016","article-title":"Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"17","author":"Jungbluth","year":"2007","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.3233\/JND-190430_ref3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.nmd.2011.03.006","article-title":"King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"21","author":"Dowling","year":"2011","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10.3233\/JND-190430_ref4","doi-asserted-by":"crossref","first-page":"E1544","DOI":"10.1002\/humu.21278","article-title":"Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion","volume":"31","author":"Clarke","year":"2010","journal-title":"Hum Mutat"},{"issue":"6","key":"10.3233\/JND-190430_ref5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/humu.22056","article-title":"Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies","volume":"33","author":"Klein","year":"2012","journal-title":"Hum Mutat"},{"key":"10.3233\/JND-190430_ref6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1172-2-25","article-title":"Central core disease","volume":"2","author":"Jungbluth H","year":"2007","journal-title":"Orphanet J Rare Dis"},{"issue":"6-8","key":"10.3233\/JND-190430_ref7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10974-008-9155-8","article-title":"Pathological defects in congenital myopathies","volume":"29","author":"Sewry CA","year":"2008","journal-title":"J Muscle Res Cell Motil"},{"issue":"18","key":"10.3233\/JND-190430_ref8","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1093\/hmg\/ddl221","article-title":"Characterization of recessive RYR1 mutations in core myopathies","volume":"15","author":"Zhou","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.3233\/JND-190430_ref9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/humu.20696","article-title":"Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores","volume":"29","author":"Monnier","year":"2008","journal-title":"Hum Mutat"},{"issue":"6","key":"10.3233\/JND-190430_ref10","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/515454","article-title":"Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle","volume":"60","author":"Monnier","year":"1997","journal-title":"Am J Hum Genet."},{"key":"10.3233\/JND-190430_ref11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2350-10-104","article-title":"The role of CACNA1S in predisposition to malignant hyperthermia","volume":"10","author":"Carpenter","year":"2009","journal-title":"BMC Med Genet"},{"issue":"7","key":"10.3233\/JND-190430_ref12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12630-010-9314-4","article-title":"A report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene","volume":"57","author":"Toppin","year":"2010","journal-title":"Can J Anaesth"},{"key":"10.3233\/JND-190430_ref13","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/ncomms2952","article-title":"Stac3 is a component of the excitation-contraction coupling machinery and mutated in Native American myopathy","volume":"4","author":"Horstick","year":"2013","journal-title":"Nat Commun"},{"issue":"39","key":"10.3233\/JND-190430_ref14","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1073\/pnas.1612441113","article-title":"Stac3 has a direct role in skeletal muscle-type excitation-contraction coupling that is disrupted by a myopathy-causing mutation","volume":"113","author":"Polster","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.3233\/JND-190430_ref15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/tra.12502","article-title":"Transport of the alpha subunit of the voltage gated L-type calcium channel through the sarcoplasmic reticulum occurs prior to localization to triads and requires the beta subunit but not Stac3 in skeletal muscles","volume":"18","author":"Linsley","year":"2017","journal-title":"Traffic"},{"issue":"4","key":"10.3233\/JND-190430_ref16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bja\/aev225","article-title":"European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility","volume":"115","author":"Hopkins","year":"2015","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.3233\/JND-190430_ref17","first-page":"511","article-title":"Standardization of the caffeine halothane muscle contracture test","volume":"69","author":"Larach","year":"1989","journal-title":"North American Malignant Hyperthermia Group. Anesth Analg"},{"key":"10.3233\/JND-190430_ref19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/bj3430039","article-title":"HEK-293 cells possess a carbachol- and thapsigargin-sensitive intracellular Ca2+store that is responsive to stop-flow medium changes and insensitive to caffeine and ryanodine","volume":"1","author":"Tong","year":"1999","journal-title":"Biochem J"},{"issue":"2","key":"10.3233\/JND-190430_ref20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JND-170210","article-title":"Functional Characterization of C-terminal Ryanodine Receptor 1 Variants Associated with Central Core Disease or Malignant Hyperthermia","volume":"4","author":"Parker","year":"2017","journal-title":"J Neuromuscul Dis"},{"issue":"3","key":"10.3233\/JND-190430_ref21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ceca.2014.07.004","article-title":"Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility","volume":"56","author":"Roesl","year":"2014","journal-title":"Cell Calcium"},{"issue":"6","key":"10.3233\/JND-190430_ref22","doi-asserted-by":"crossref","first-page":"e0130606","DOI":"10.1371\/journal.pone.0130606","article-title":"Divergent Activity Profiles of Type 1 Ryanodine Receptor Channels Carrying Malignant Hyperthermia and Central Core Disease Mutations in the Amino-Terminal Region","volume":"10","author":"Murayama","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.3233\/JND-190430_ref23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/0310057X18811816","article-title":"Masseter muscle rigidity and the role of DNA analysis to confirm malignant hyperthermia susceptibility","volume":"47","author":"Hudig","year":"2019","journal-title":"Anaesth Intensive Care"},{"issue":"5","key":"10.3233\/JND-190430_ref24","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/0310057X1103900514","article-title":"Safety of exposure of malignant hyperthermia non-susceptible patients and their relatives to anaesthetic triggering agents","volume":"39","author":"Pollock","year":"2011","journal-title":"Anaesth Intensive Care"},{"issue":"16","key":"10.3233\/JND-190430_ref25","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.3233\/JND-190430_ref26","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/ALN.0b013e3181d69283","article-title":"Functional studies of RYR1 mutations in the skeletal muscle ryanodine receptor using human RYR1 complementary DNA","volume":"112","author":"Sato","year":"2010","journal-title":"Anesthesiology"},{"issue":"2","key":"10.3233\/JND-190430_ref27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ab.2007.11.019","article-title":"Identification of ryanodine receptor 1 single-nucleotide polymorphisms by high-resolution melting using the LightCycler 480 System","volume":"374","author":"Grievink","year":"2008","journal-title":"Anal Biochem"},{"key":"10.3233\/JND-190430_ref28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"issue":"1","key":"10.3233\/JND-190430_ref29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/ALN.0b013e31828cebfe","article-title":"Skeletal muscle ryanodine receptor mutations associated with malignant hyperthermia showed enhanced intensity and sensitivity to triggering drugs when expressed in human embryonic kidney cells","volume":"119","author":"Sato","year":"2013","journal-title":"Anesthesiology"},{"issue":"10","key":"10.3233\/JND-190430_ref30","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"issue":"5","key":"10.3233\/JND-190430_ref31","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/ALN.0000000000000610","article-title":"Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness","volume":"122","author":"Fiszer","year":"2015","journal-title":"Anesthesiology"},{"issue":"7","key":"10.3233\/JND-190430_ref32","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/humu.22326","article-title":"RyR1 deficiency in congenital myopathies disrupts excitation-contraction coupling","volume":"34","author":"Zhou","year":"2013","journal-title":"Hum Mutat"},{"issue":"5","key":"10.3233\/JND-190430_ref33","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/ALN.0b013e3182a8a8e7","article-title":"Using exome data to identify malignant hyperthermia susceptibility mutations","volume":"119","author":"Gonsalves","year":"2013","journal-title":"Anesthesiology"},{"issue":"Pt 8","key":"10.3233\/JND-190430_ref34","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/brain\/awm096","article-title":"Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies","volume":"130","author":"Zhou","year":"2007","journal-title":"Brain"},{"issue":"4","key":"10.3233\/JND-190430_ref35","doi-asserted-by":"crossref","first-page":"E575","DOI":"10.1002\/humu.20991","article-title":"Functional characterization of ryanodine receptor (RYR1) sequence variants using a metabolic assay in immortalized B-lymphocytes","volume":"30","author":"Zullo","year":"2009","journal-title":"Hum Mutat"},{"issue":"5","key":"10.3233\/JND-190430_ref36","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1399-0004.2010.01493.x","article-title":"Novel missense mutations and unexpected multiple changes of RYR1 gene in 75 malignant hyperthermia families","volume":"79","author":"Tammaro","year":"2011","journal-title":"Clin Genet"},{"issue":"4","key":"10.3233\/JND-190430_ref37","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.bja.2018.06.028","article-title":"Genetic epidemiology of malignant hyperthermia in the UK","volume":"121","author":"Miller","year":"2018","journal-title":"Br J Anaesth"},{"issue":"7532","key":"10.3233\/JND-190430_ref38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature14063","article-title":"Structure of the rabbit ryanodine receptor RyR1 at near-atomic resolution","volume":"517","author":"Yan","year":"2015","journal-title":"Nature"},{"key":"10.3233\/JND-190430_ref39","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1038\/ncomms8947","article-title":"Crystal structures of ryanodine receptor SPRY1 and tandem-repeat domains reveal a critical FKBP12 binding determinant","volume":"6","author":"Yuchi","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.3233\/JND-190430_ref40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bja.2018.08.009","article-title":"Abnormal calcium signalling and the caffeine-halothane contracture test","volume":"122","author":"Figueroa","year":"2019","journal-title":"Br J Anaesth"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-190430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:49:24Z","timestamp":1777506564000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-190430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":39,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jnd-190430","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]}}}